Skip to main content

Endometrial Cancer and HNPCC

Lynch Syndrome: HNPCC

There are many reasons to wonder about your risk of colorectal or endometrial cancer - your environment, your diet, your family history. As many as 150,000 new cases of colorectal cancer and over 40,000 cases of endometrial cancer are diagnosed each year.

While the majority of colorectal and endometrial cancers are sporadic, or not caused by inherited risk factors, research has shown that up to ten percent of these cases are due to inherited cancer syndromes. One of these inherited syndromes is known as hereditary nonpolyposis colorectal cancer (HNPCC). Individuals with HNPCC have up to an 80 percent risk of colorectal cancer and up to a 71 percent risk of endometrial cancer by age 70. This is a large risk compared to the general population's risk, which is just two percent for colorectal cancer and 1.5 percent for endometrial cancer.

Additionally, people with HNPCC may have more than one type of cancer. These cancers may be diagnosed at the same or at different times. Along with colorectal and endometrial cancer, other HNPCC-related cancers include ovarian, stomach, kidney/urinary tract, brain, biliary tract, pancreas, small bowel, and sebaceous adenomas. It is important to check your family history for these cancers in addition to colorectal and/or endometrial cancers.

Inherited Risk FactorsMany individuals are unaware of their inherited risk. Whether or not you've had cancer yourself, a family history of early onset colorectal and/or endometrial cancer, or other HNPCC-related cancers at any age, is suspicious for inherited colorectal cancer.

What do we mean by inherited colorectal cancer?

We're all born with two copies of about 30,000 different genes, one copy of each gene from our mother and the other from our father. Three genes in particular, MLH1, MSH2 and MSH6 are responsible for the majority of HNPCC. We all have these genes. When functioning normally, these genes work to prevent certain cancers. But in some cases, we can inherit a mutation in one of these genes from either parent. This mutation interferes with the normal activity of the gene, making us more susceptible to colorectal, endometrial and other types of cancer. It is important to remember that although cancer risks are increased in HNPCC, they are not 100%-therefore, not all people with HNPCC will develop cancer.

If a person has an HNPCC mutation, their parents, children, brothers and sisters may also have the same mutation. Genetic testing is the only way to accurately identify individuals who carry mutations in these genes. If genetic testing leads to a diagnosis of HNPCC in an individual, it is very important for them to share their test results with family members. hare their test results with family members.

» Reducing the Risk of Colorectal Cancer: HNPCC

Comments

Popular posts from this blog

Cancer Survivors

Just read a story about one woman's cancer experience. I bet everyone has a story about what goes through your mind when you are told you have cancer. Her thought were about her stunned family members, one crying and the other in shock. I bet there are quite a few stories that could be qualitatively studied. Those experiences could help nurses better help patients during this time.

Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer

Key Points Question    What is the frequency and spectrum of cancer susceptibility gene mutations among patients with colorectal cancer diagnosed at younger than 50 years? Findings    In this cohort study of 450 patients with early-onset colorectal cancer, 72 (16%) had a pathogenic mutation. Panel testing identified mutations in patients that may have otherwise been missed; specifically, 24 of 72 patients (33.3%) who were mutation positive did not meet testing criteria for the gene(s) in which they had a mutation. Meaning    Multigene panel testing should be considered for all patients with early-onset colorectal cancer. Read More:   Prevalence and Spectrum of Gene Mutations and Colorectal Cancer

Preventative Measures for Carriers

Reducing the Risk of Colon Cancer Here are some of the preventive steps you and your doctor can take if your genetic test indicates a risk of developing an inherited cancer: Increased Surveillance Colonoscopy every one to two years beginning at age 20-25 or 5-10 years before the earliest age of a diagnosed colorectal cancer in your family, whichever comes first. Colonoscopy annually after age 40. Preventive Surgery If colon cancer (or an advanced precancerous polyp) is diagnosed in a patient with HNPCC , a full, rather than partial, colectomy is recommended. In carefully selected people, for example, those not willing or able to undergo periodic screening, preventive colectomy may be an option based on a positive genetic test result for HNPCC. Preventive Drug Therapies for Colorectal Cancer: Different drugs for the prevention of colorectal cancer are currently being researched for individuals with HNPCC. None of these drugs are currently approved by the FDA for this purpose. Increa...